You are correct about maximum amount of impairment over goodwill.
To judge whether a stock undervalued or not, future earnings will be more appropriate.
Based on recent announcements, I calculated ARI would generate EBITDA between $491m - $644m p.a. That would be far enough to support current market cap of $602m.
AGO, is currently producing at loss, as break even point is US$68/t IO62%.
MGX, would be producing at break even point at best, and unknown bill on broken sea wall.
BCI, would be producing at approx. 2/t marginal profit. But production life and scale is limited.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 117898 | 4 |
View Market Depth
| Last trade - 16.25pm 18/07/2025 (20 minute delay) ? |
| ARI (ASX) Chart |
Day chart unavailable